耶鲁教授或入主NIH FDA易主

　　

生物通报道，据The Washington Post消息，纽约市前卫生专员Margaret Hamburg可能成为FDA新任局长。

 

美国总统奥巴马计划提名纽约市前卫生专员Margaret Hamburg为国家食品药物管理局（FDA）局长。同时与她共同入住FDA的还有马里兰州巴尔第摩市（Baltimore）前卫生专员Joshua Sharfstein（现任奥巴马政府过渡团队FDA代理局长），Joshua可能成为Margaret Hamburg的副手。该提名可能于本周宣布，然後还需获得参议院批准。

 

据路透社报道，公共卫生官员们对这一消息表示欢迎。美国消费者联盟食品政策主管Jean Halloran表示：“FDA局长是联邦政府中最重要也是最难做的职位之一。提名Hamburg出任该职位将意味着FDA在面临严峻挑战之际终于会有一位具备领导能力的掌门人。”

 

前总统布什在任的八年间，FDA有一半多时间都没有常设局长，同时该机构还遭遇一连串药品安全和食品受污染事件。FDA还被指责允许政治干预科学。

 

Hamburg从1990年代开始服务于纽约市卫生管理署，在此之前，她曾在美国国立卫生研究所旗下的过敏与传染病研究所工作。之后，在克林顿政府时期，Margaret Hamburg曾是健康与社会服务部（Department of Health and Human Services）反生化恐怖部门的管理者。Margaret Hamburg现在还任“核威胁倡议”（Nuclear Threat Initiative）组织生物项目部门的副主席。

 

NIH可能易主？

另外NIH被传出可能易主，目前谣言四起。据In Vivo的博客报道称，耶鲁大学的遗传学家Richard  Lifton可能与国立人类基因组学研究所所长Francis Collins以及国立心肺血液疾病研究所所长共同入主NIH。

 

原文报道：FDA head chosen, NIH names swirling

Former New York City health commissioner Margaret Hamburg seems to be the Obama administration's pick to head the embattled Food and Drug Administration, with Baltimore health commissioner Joshua Sharfstein slated to serve as FDA's deputy commissioner, according to The Washington Post.

 

Hamburg served as NYC health commissioner for much of the 1990s, after a brief stint at the National Institutes of Health's National Institute of Allergy and Infectious Diseases. She later served under President Bill Clinton as an administrator focused on bioterrorism at the Department of Health and Human Services, and is currently vice president for biological programs at the Nuclear Threat Initiative, a non-profit organization cofounded by media magnate Ted Turner that addresses global threats from nuclear, biological and chemical weapons.

 

Obama is expected to announce his choice of Hamburg soon, after which she will face Congressional confirmation. Sharfstein, whose name was previously bandied about as a potential FDA head, will not require such confirmation.

 

Rumors about who will lead the National Institutes of Health are also swirling. The In Vivo blog reported yesterday that Yale geneticist Rick Lifton is in the running for NIH director, along with former National Human Genome Research Institute head Francis Collins and National Heart Lung and Blood Institute director Elizabeth Nabel.